Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
EyeTechCare
Main outcome criteria:
Reduction of aqueous humor flow at 6 months compared with the pretreatment of aqueous humor flow.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
refractory primary open-angle glaucoma (POAG)
IOP\> 21 mm Hg and \<32 mm Hg with an optimal treatment.
Lack of history of cyclo-destruction of the ciliary body (laser diode, cold ...)
Lack of intraocular surgery or laser therapy in the eye seen in the three months preceding the date of HIFU treatment.
Male or female age (s) of at least 18 and able to give informed consent
Patient who signed the informed consent form
Patient affiliated to a social security scheme
You may not be if
History of glaucoma by placing a drainage implant (valves, pipes ...)
previous refractive procedures preventing accurate measurement of intraocular pressure (PRK, LASIK)
General treatment which may alter IOP began in the month before the HIFU procedure
Patient monophthalmus
thyroid orbitopathy
History of ocular or retrobulbar tumor
Cyclodialysis
choroidal hematoma or uprising choroidal
Anatomy of the eyeball inadequate treatment or medical device (eye too small or too large)
Pregnancy, breastfeeding, lack of contraceptive use among women at risk of having a child
Participation in another clinical investigation of a medical or surgical treatment can affect the intraocular pressure in the three months preceding the HIFU